Past experience and future studies with antilymphocyte globulin in recipients of kidney homografts

C. W. Putnam; R. H. Bell; R. W. Beart; J. T. Anderson; R. Weil IIIrd

Past experience and future studies with antilymphocyte globulin in recipients of kidney homografts

C. W. Putnam
, R. H. Bell
, R. W. Beart
, J. T. Anderson
, R. Weil IIIrd

Research output: Contribution to journal › Article › peer-review

Abstract

We remain convinced that antilymphocyte globulin (ALG) is a potent immunosuppressive agent in humans. For that reason, we have used it in essentially every case of renal transplantion since May of 1966; now, however, we are about to embark on a controlled clinical trial of ALG in kidney transplantation and await with tremendous interest the results of other such trials from other centres around the world.

Original language	English (US)
Pages (from-to)	59-63
Number of pages	5
Journal	Postgraduate Medical Journal
Volume	52
Issue number	Sup.5
State	Published - 1976
Externally published	Yes

ASJC Scopus subject areas

General Medicine

Cite this

@article{76bd3737fabf46f9bb58c7fd2bf8362a,

title = "Past experience and future studies with antilymphocyte globulin in recipients of kidney homografts",

abstract = "We remain convinced that antilymphocyte globulin (ALG) is a potent immunosuppressive agent in humans. For that reason, we have used it in essentially every case of renal transplantion since May of 1966; now, however, we are about to embark on a controlled clinical trial of ALG in kidney transplantation and await with tremendous interest the results of other such trials from other centres around the world.",

author = "Putnam, \{C. W.\} and Bell, \{R. H.\} and Beart, \{R. W.\} and Anderson, \{J. T.\} and \{Weil IIIrd\}, R.",

note = "Funding Information: This work was supported by research grants from the United States Public Health Service (AR44731, AR40391, and AI44074).",

year = "1976",

language = "English (US)",

volume = "52",

pages = "59--63",

journal = "Postgraduate Medical Journal",

issn = "0032-5473",

publisher = "BMJ Publishing Group",

number = "Sup.5",

}

TY - JOUR

T1 - Past experience and future studies with antilymphocyte globulin in recipients of kidney homografts

AU - Putnam, C. W.

AU - Bell, R. H.

AU - Beart, R. W.

AU - Anderson, J. T.

AU - Weil IIIrd, R.

N1 - Funding Information: This work was supported by research grants from the United States Public Health Service (AR44731, AR40391, and AI44074).

PY - 1976

Y1 - 1976

N2 - We remain convinced that antilymphocyte globulin (ALG) is a potent immunosuppressive agent in humans. For that reason, we have used it in essentially every case of renal transplantion since May of 1966; now, however, we are about to embark on a controlled clinical trial of ALG in kidney transplantation and await with tremendous interest the results of other such trials from other centres around the world.

AB - We remain convinced that antilymphocyte globulin (ALG) is a potent immunosuppressive agent in humans. For that reason, we have used it in essentially every case of renal transplantion since May of 1966; now, however, we are about to embark on a controlled clinical trial of ALG in kidney transplantation and await with tremendous interest the results of other such trials from other centres around the world.

UR - https://www.scopus.com/pages/publications/0017034104

UR - https://www.scopus.com/pages/publications/0017034104#tab=citedBy

M3 - Article

C2 - 792847

SN - 0032-5473

VL - 52

SP - 59

EP - 63

JO - Postgraduate Medical Journal

JF - Postgraduate Medical Journal

IS - Sup.5

ER -

Past experience and future studies with antilymphocyte globulin in recipients of kidney homografts

Abstract

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this